Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 4 (2007), Issue 6 (June)

1. Expression of Bax, Bcl-xL and Bcl-2 proteins in relation to grade of inflammation and stage of fibrosis in chronic hepatitis C.
   Histopathology, 50(7): 928-35. [Abstract] [Full-text]
2. Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis.
   Hepatology, 45(6): 1496-505. [Abstract] [Full-text]
3. Endotoxemia produces coma and brain swelling in bile duct ligated rats.
   Hepatology, 45(6): 1517-26. [Abstract] [Full-text]
4. The mannose receptor on murine liver sinusoidal endothelial cells is the main denatured collagen clearance receptor.
   Hepatology, 45(6): 1454-61. [Abstract] [Full-text]
5. Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis.
   Hepatology, 45(6): 1375-81. [Abstract] [Full-text]
6. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
   Hepatology, 45(6): 1366-74. [Abstract] [Full-text]
7. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
   Cancer, 109(12): 2490-6. [Abstract] [Full-text]
8. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.
   Gut, 56(7): 968-73. [Abstract] [Full-text]
9. Computer-aided diagnosis of hepatic fibrosis: preliminary evaluation of MRI texture analysis using the finite difference method and an artificial neural network.
   AJR Am J Roentgenol, 189(1): 117-22. [Abstract] [Full-text]
10. Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
    Transpl Int, 20(7): 583-90. [Abstract] [Full-text]
11. Bacterial infection-related morbidity and mortality in cirrhosis.
    Am J Gastroenterol, 102(7): 1510-7. [Abstract] [Full-text]
12. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Am J Gastroenterol, 102(7): 1397-405. [Abstract] [Full-text]
13. Expression of angiotensin II receptor type 1 is reduced in advanced rat liver fibrosis.
    Dig Dis Sci, 52(8): 1995-2005. [Abstract] [Full-text]
14. Liver fibrosis: a balance of ACEs?
    Clin Sci (Lond), 113(3): 109-18. [Abstract] [Full-text]

© 2004-2010 Liver Cirrhosis Research Today. All Rights Reserved.